Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

Kostiantyn Dymynchuk preaches in penal facilities and was formally diagnosed with hepatitis C in 2008. Ukraine, 2018. Photograph by Alexsandr Glyadyelov

Kostiantyn thinks he contracted hepatitis C in 1996. He was formally diagnosed in 2008. Since then he started to seriously look after his health.

Feature story
Feature story |
30 July 2018
Hepatitis C
Ukraine

Out of darkness: People living with hepatitis C

7 min
Community ART Groups (CAGs) talking about the importance of good treatment adherence, Malawi 2017. Photograph by Luca Sola
Feature story
Feature story |
23 July 2018
HIV/AIDS
MalawiMozambiqueIndia

Meeting the specific needs of key populations living with HIV – MSF’s experience

6 min
Registration area to define which vaccine children should receive. Photograph by Pierre-Yves Bernard
Feature story
Feature story |
19 July 2018
Vaccines
Central African Republic

The outcome of the two years mass vaccination campaign in Central African Republic

4 min
MSF staff giving vaccinations in Douentza, Mali. Photograph by Seydou Camara Photograph by Seydou Camara
Feature story
Feature story |
12 April 2018
Vaccines
Mali

Mali: Vaccinating 10,000 children over 60,000km of desert roads

3 min
Photograph by Ravi Mishra Photograph by Ravi Mishra
Feature story
Feature story |
06 March 2018
Hepatitis C

One year in Uttar Pradesh, Savantee Ghosh

3 min
Photograph by Ravi Mishra Photograph by Ravi Mishra
Feature story
Feature story |
05 March 2018
Hepatitis C
India

One year, 1,198 people with Hep C in Uttar Pradesh, MSF’s hepatitis project

4 min
A client at the Mith Samlanh Drop-In Centre, which offers medical support, food and a resting area. Photograph by Todd Brown
Feature story
Feature story |
05 March 2018
Hepatitis C

Cambodia: Going the extra mile for people who inject drugs

Simphiwe holds his medication, he takes up to 26 pills a day to treat XDR-TB. Here he holds his morning selection, which includes delamanid, one of the newest DR-TB drugs, which Simphiwe is taking for the first time today. Photograph by Sydelle Willow Smith
Feature story
Feature story |
14 February 2018
Tuberculosis

Treating drug-resistant TB: “Some of our patients simply can’t wait for clinical trials”

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury